Literature DB >> 4073861

In vitro susceptibilities of 25 Giardia lamblia isolates of human origin to six commonly used antiprotozoal agents.

B Gordts, W Hemelhof, C Asselman, J P Butzler.   

Abstract

The role drug resistance plays in the occurrence of chronic and recurrent giardiasis has not been established. Extensive data on the susceptibility to antimicrobial agents of living Giardia spp. trophozoites from human origin are lacking. We have determined with a macrodilution method in semisolid medium the in vitro susceptibility of 25 Giardia lamblia isolates, all obtained by routine cultivation of the duodenal fluid of children to six commonly used antiprotozoal drugs. The results showed tinidazole to be the most active drug (all isolates have MICs of less than or equal to 0.5 micrograms/ml). Metronidazole was equally active on all but one isolate, for which an MIC between 0.5 and 1 micrograms/ml was found. Furazolidone was the most active nonimidazole compound tested. More than 50% of the isolates were very susceptible to paromomycin, pyrimethamine, and chloroquine. Two of the strains presented an MIC for paromomycin higher than 10 micrograms/ml, and six strains needed more than 50 micrograms of pyrimethamine per ml to be inhibited. Decreased susceptibility of several of the isolates to different agents appears to be linked.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4073861      PMCID: PMC180257          DOI: 10.1128/AAC.28.3.378

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  12 in total

1.  The treatment of Giardia lamblia infection with mepacrine, metronidazole and furazolidone.

Authors:  S Bassily; Z Farid; J W Mikhail; D C Kent; J S Lehman
Journal:  J Trop Med Hyg       Date:  1970-01

2.  [Therapeutic trials with 5 drugs in lambliasis].

Authors:  H Palomino; C Pérez; R Donckaster; J Sapunar; M Gabor; A Atías; V Parodi; L Narbona
Journal:  Bol Chil Parasitol       Date:  1970 Jan-Jun

3.  Routine culture of Giardia lamblia trophozoites from human duodenal aspirates.

Authors:  B Gordts; W Hemelhof; P Retoré; M Rahman; S Cadranel; J P Butzler
Journal:  Lancet       Date:  1984-07-21       Impact factor: 79.321

4.  Inhibition of clonal growth of Giardia lamblia and Entamoeba histolytica by metronidazole, quinacrine, and other antimicrobial agents.

Authors:  F D Gillin; L S Diamond
Journal:  J Antimicrob Chemother       Date:  1981-10       Impact factor: 5.790

5.  Efficacy of various drugs for treatment of giardiasis. A comparative study.

Authors:  G C Levi; C A de Avila; V Amato Neto
Journal:  Am J Trop Med Hyg       Date:  1977-05       Impact factor: 2.345

Review 6.  Treatment of giardiasis: literature review and recommendations.

Authors:  S J Lerman; R A Walker
Journal:  Clin Pediatr (Phila)       Date:  1982-07       Impact factor: 1.168

7.  Giardiasis.

Authors:  M S Wolfe
Journal:  JAMA       Date:  1975-09-29       Impact factor: 56.272

8.  In vitro inhibition of Giardia lamblia and Trichomonas vaginalis growth by bithionol, dichlorophene, and hexachlorophene.

Authors:  T Takeuchi; S Kobayashi; M Tanabe; T Fujiwara
Journal:  Antimicrob Agents Chemother       Date:  1985-01       Impact factor: 5.191

9.  Chronic giardiasis: studies on drug sensitivity, toxin production, and host immune response.

Authors:  P D Smith; F D Gillin; W M Spira; T E Nash
Journal:  Gastroenterology       Date:  1982-10       Impact factor: 22.682

10.  Techniques of axenic cultivation of Entamoeba histolytica Schaudinn, 1903 and E. histolytica-like amebae.

Authors:  L S Diamond
Journal:  J Parasitol       Date:  1968-10       Impact factor: 1.276

View more
  7 in total

1.  A new screening assay for antigiardial compounds: effects of various drugs on the adherence of Giardia duodenalis to Caco2 cells.

Authors:  L Favennec; C Chochillon; D Magne; D Meillet; D Raichvarg; J Savel; J G Gobert
Journal:  Parasitol Res       Date:  1992       Impact factor: 2.289

2.  Routine in vitro cultivation of Giardia lamblia by using the string test.

Authors:  S H Korman; E Hais; D T Spira
Journal:  J Clin Microbiol       Date:  1990-02       Impact factor: 5.948

3.  In vitro activity of antiprotozoal drugs against Giardia intestinalis of human origin.

Authors:  B Gordts; J De Jonckheere; W Kasprzak; A C Majewska; J P Butzler
Journal:  Antimicrob Agents Chemother       Date:  1987-04       Impact factor: 5.191

Review 4.  Treatment of giardiasis.

Authors:  T B Gardner; D R Hill
Journal:  Clin Microbiol Rev       Date:  2001-01       Impact factor: 26.132

5.  Investigation of human giardiasis by karyotype analysis.

Authors:  S H Korman; S M Le Blancq; R J Deckelbaum; L H Van der Ploeg
Journal:  J Clin Invest       Date:  1992-06       Impact factor: 14.808

6.  Evaluation of a new method for routine in vitro cultivation of Giardia lamblia from human duodenal fluid.

Authors:  B Gordts; W Hemelhof; K Van Tilborgh; P Retoré; S Cadranel; J P Butzler
Journal:  J Clin Microbiol       Date:  1985-11       Impact factor: 5.948

Review 7.  The biology of Giardia spp.

Authors:  R D Adam
Journal:  Microbiol Rev       Date:  1991-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.